WhatsApp Skip to main content

Dr. Harsh J Shah

Colon Cancer Pathology Report: What the Terms Mean

Last updated: 22-Nov-2026

Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Dr Harsh Shah, gastro and cancer surgeon, Ahmedabad

Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Gastro & Cancer Surgeon
Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad · 18 years of experience

In short

Most colon cancers are adenocarcinomas. The report also gives the grade, the depth, the lymph nodes and the margins, and these decide the plan.

Four tumour tests matter most: MMR or MSI status, RAS, BRAF and HER2. They guide chemotherapy, immunotherapy and targeted drugs.

Ask for these tests early, on the biopsy. Then your surgeon and oncologist can plan one treatment path without delay.

The full plan for surgery and chemotherapy is on our colon cancer treatment page. This post explains what the pathology report says.

What does a colon cancer pathology report tell you?

It names the type of cancer, how abnormal the cells look, how deep it has grown and whether nodes and margins are clear.

A pathologist studies the biopsy or the removed colon under the microscope. The report is the map your team uses to plan treatment. Two reports matter. The first comes from the biopsy, before surgery. The second comes from the removed colon, after surgery.

The biopsy report confirms cancer and often carries the tumour tests. The surgery report adds the final stage, the lymph node count and the margins. Our post on how colon cancer is staged explains what the T and N letters mean.

Which types of colon cancer are there?

Most colon cancers are ordinary adenocarcinomas. A few are mucinous, signet-ring or medullary types, and these behave a little differently.

Types of colon cancer on a pathology report
TypeWhat it means for you
AdenocarcinomaGland-forming cancer. The usual type, and the one most treatment advice is built on.
Mucinous adenocarcinomaCells float in pools of mucus. More often on the right side, and often linked to MMR loss.
Signet-ring cell carcinomaUncommon and more aggressive. Can spread along the lining of the belly, so staging needs extra care.
Medullary carcinomaUncommon, mostly on the right side, almost always MMR deficient. Often behaves better than it looks.
Serrated adenocarcinomaGrows from a serrated polyp. Often carries the BRAF change.
Neuroendocrine carcinomaRare and fast growing. Treated differently from usual colon cancer.

Mucinous and signet-ring types are seen a little more often in young Indian patients. If you are young, ask for the MMR test and a careful staging scan.

What do grade and the other features mean?

Grade tells how abnormal the cells look. Budding, vein invasion and nerve invasion show how likely the cancer is to spread or return.

Grade runs from well to poorly differentiated. A poorly differentiated tumour looks less like normal gut tissue. One exception matters. An MMR-deficient tumour can look poorly differentiated and still behave well.

These features are not part of the stage. They still change decisions, especially in stage II disease.

  • Tumour budding: single cells or tiny clusters at the edge of the growth.
  • Lymphovascular invasion: cancer cells seen inside small vessels.
  • Perineural invasion: cancer cells tracking along a nerve.
  • Tumour deposits: small cancer nodules in the fat near the bowel, counted as a node finding.

When several of these are present in stage II, your team may advise chemotherapy after surgery. Our post on treatment for stage 1 to 3 colon cancer explains how that decision is made.

What is MMR or MSI testing?

MMR testing checks four repair proteins in the tumour. If they are missing, the tumour is called MMR deficient, or MSI-high.

Cells have a spell-check system that repairs copying errors in DNA. In some tumours it is switched off. Such a tumour collects many errors and is easy for the immune system to spot.

The test uses a stain on the biopsy sample. It looks for four proteins called MLH1, MSH2, MSH6 and PMS2. When it is equivocal, a second test called MSI-PCR is done. Every colon cancer should have this test.

Why the MMR result matters
ResultWhat changes
MMR deficient, stage IIChemotherapy with 5-FU alone is usually not helpful, so it is often skipped.
MMR deficient, stage IIIOxaliplatin-based chemotherapy still helps and is usually given.
MMR deficient, stage IVImmunotherapy is usually the first choice, ahead of chemotherapy.
MMR deficient, any stagePossible Lynch syndrome. Genetic testing and family screening may be advised.
MMR proficientStandard chemotherapy plan. Immunotherapy rarely helps in the usual setting.

Not every MMR-deficient tumour is inherited. Many arise by chance in older people, usually on the right side. A genetic counsellor sorts out which is which. This is the link to our hereditary risk work, and it can matter for your children and brothers and sisters.

What are RAS, BRAF and HER2?

These are three tumour changes that decide which targeted drugs can be used when colon cancer has spread. They are tested on the tumour, not the blood.

  • RAS (KRAS and NRAS): a change here means anti-EGFR drugs such as cetuximab will not work. Every gene spot must be tested, not only one.
  • BRAF V600E: a change here often means a tougher cancer, and a targeted combination of encorafenib and cetuximab can be used.
  • HER2: an excess of this protein is uncommon. It opens the way to HER2-targeted drugs when other options are used up.

A few other changes, such as NTRK fusions and KRAS G12C, are rare but have specific drugs. A broad gene panel on the tumour covers all of them in one go.

These tests are mainly for cancer that has spread. Our post on stage 4 colon cancer treatment shows how the results shape the drug choice. In early cancer, MMR is a must, and the other tests are often done at diagnosis so they are ready if the cancer ever returns.

What are the molecular subtypes?

Researchers sorted colon cancer into four consensus molecular subtypes, CMS1 to CMS4, by gene activity. They explain behaviour but do not yet choose treatment.

The four consensus molecular subtypes
SubtypeMain feature
CMS1MMR deficient, many immune cells, often right-sided and BRAF changed
CMS2The classic pathway, mostly left-sided, with a good outlook
CMS3Metabolic type, often with a RAS change
CMS4Scar-like tissue around the tumour, often advanced, with the poorest outlook

CMS needs gene activity tests that routine hospital labs do not run. In day-to-day care, the MMR, RAS, BRAF and HER2 results do the work. If a research report mentions a CMS type, this table is a rough guide to it.

How do these results change treatment?

They decide whether you need chemotherapy after surgery, whether immunotherapy is a choice, and which targeted drug suits you if the cancer spreads.

Dr Harsh Shah reads the report with the scans before any plan is made. The surgery itself is planned from the scans, the site of the growth and your fitness. The report then adds the drug side of the plan.

  • MMR status steers stage II decisions and opens the immunotherapy route.
  • Lymph node count and margins show whether the operation was complete.
  • Budding, vein and nerve invasion help decide on chemotherapy in stage II.
  • RAS, BRAF and HER2 pick the targeted drug if the cancer spreads.
  • Signet-ring cells raise the question of a laparoscopic look at the belly lining.

If the report does not show MMR status, the node count or the margins, ask the pathologist to review it before any chemotherapy decision.

What should a good pathology report include?

A complete report gives the site, size, type, grade, depth, margins, node count, invasion findings and MMR status. Missing items should be asked for.

Checklist for a colon cancer surgery report
ItemWhy it is needed
Type and gradeTells how the cancer is expected to behave
Depth of growth (T)Part of the stage
Margins (cut ends and the deep edge)Shows if the cancer was fully removed
Lymph nodes: number found and number involvedPart of the stage. At least 12 nodes should be examined.
Invasion of veins, nerves and tumour depositsGuides the chemotherapy decision
MMR or MSI statusGuides chemotherapy and immunotherapy

Node counting varies between laboratories. A wider operation that removes the blood supply at its root, called complete mesocolic excision, usually yields more nodes. Your surgeon can ask the laboratory to look for them carefully.

What should you bring to the consultation?

Bring the biopsy and surgery reports, the stained slides or blocks, all scans and any gene test reports. The first visit then lists what is still missing.

Many people have had a biopsy elsewhere. Slides and blocks can be sent to a second laboratory for the MMR and gene tests, so the sample does not need to be taken again. Dr Harsh Shah will go through the report with you in plain words and tell you which tests are still needed. He operates by the laparoscopic or open route, whichever is safer for the person.

Frequently asked questions

What is a pathology report in colon cancer?

It is the pathologist's written findings on the biopsy or the removed colon. It names the cancer type, grade, depth, nodes and margins, and it guides treatment.

What does MMR deficient or MSI-high mean?

The tumour has lost its DNA repair proteins. It can respond very well to immunotherapy, and it may point to an inherited cause such as Lynch syndrome.

Do all colon cancers need MMR testing?

Yes. It is a basic test on every colon cancer. It is done on the biopsy and guides chemotherapy, immunotherapy and family screening.

Why is the RAS result important?

A RAS change means anti-EGFR drugs such as cetuximab will not work. It is checked before these drugs are used for spread cancer.

What is BRAF V600E?

It is a gene change in some colon cancers. It often goes with a harder-to-treat tumour, and a targeted drug combination is available for it.

Is a poorly differentiated tumour always serious?

Usually it points to a more aggressive cancer. An MMR-deficient tumour can look poorly differentiated yet behave better, so grade is read together with MMR.

Can the tests be done on an old biopsy?

Often yes. The stored slides or blocks can be sent for MMR and gene tests, so a fresh biopsy is not always needed.

Related pages

For surgery and chemotherapy, start at the colon cancer treatment page. For questions before you travel, call +91-63555-64601.

Where Dr Harsh Shah sees patients and operates

Dr Harsh Shah — Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad
Dr. Jivraj Mehta Hospital, Dr Jivraj Mehta Marg, Vasna, Ahmedabad 380007.
Consultations, review of reports and scans, operations and follow-up. OPD Monday to Saturday, 9 am to 5 pm.
Appointments: +91-63555-64601 · +91-63590-11009 · Hospital 079-2663 6363
Directions to the hospital · WhatsApp +91-63555-64601

Got a pathology report that talks about MMR, grade or molecular markers, and unsure what it means? Dr Harsh Shah, a gastro and cancer surgeon in Ahmedabad, explains the terms and how they shape treatment. You can also call us or write on WhatsApp. Call For Appointment Book on WhatsApp Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Get health updates from Dr Harsh Shah on WhatsApp

Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.

Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.

Dr. Harsh J Shah
Dr Harsh Shah, Gastro, Cancer & Laparoscopic Surgeon, Ahmedabad
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.